1. Bartus RT, Dean RL and Beer B (1980): Memory deficits in aged Cebus monkeys and facilitation with central cholinomimetics. Neurobiol Aging 1: 145–152.
2. Bottini G, Vallar G, Cappa S, Monza GC, Scarpini E, Baron P, Cheldi A and Scarlato G (1992): Oxiracetam in dementia: a double-blind, placebo-controlled study. Acta Neurol Scand 86: 237–241.
3. Chleide E, Bruhwyler J and Mercier M (1991): Enhanced resistance effect of piracetam upon hypoxia-induced impaired retention of fixed-interval responding in rats. Pharmacol Biochem Behav 40: 1–6.
4. Copani A, Genazzani A, Aleppo G, Casabona G, Canonico PL, Scapagnini and Nicoletti F (1992): Nootropic drugs positively modulate a-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures. J Neurochem 58: 1199–1204.
5. Davis KL, Thal LJ, Gamze ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, Morris JC, Kawas CH, Knopman DS, Earl NL, Kumar and Doody RS (1992): A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer’s disease. New Engl J Med 327: 1253–1259.